Clinical Trial Update: Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of Orforglipron in participants with Peripheral Arterial Disease is currently recruiting. The trial is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Orforglipron (orforglipron)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Peripheral Arterial Disease | Phase 3 | Status: RECRUITING